{"name":"Sysmex Corporation","slug":"sysmex","ticker":"6869","exchange":"TSE","domain":"sysmex.co.jp","description":"Sysmex Corporation  is a Japanese company headquartered in Kobe that is engaged in the health care business. Originally called TOA Medical Electronics, the Sysmex brand was established in 1978, and were mainly involved with haematology analysers. The company was renamed Sysmex Corporation in 1998 taking advantage of brand recognition of their machines.","hq":"Kobe, Japan","founded":1968,"employees":"10533","ceo":"Hisashi Ietsugu","sector":"MedTech / IVD","stockPrice":1343,"stockChange":1,"stockChangePercent":0.07,"marketCap":"$5.3B","metrics":{"revenue":3179553693.7791357,"revenueGrowth":0,"grossMargin":51.9,"rdSpend":0,"netIncome":282891122.9235958,"cash":478945006.4655967,"dividendYield":2.68,"peRatio":17.9,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2023-02-09","type":"earnings","headline":"Sysmex Corporation Announces FY2022 Financial Results","summary":"Sysmex reported a net income of ¥43.4 billion for FY2022, up 10.4% from the previous year.","drugName":"","sentiment":"positive"},{"date":"2022-09-01","type":"deal","headline":"Sysmex Partners with Roche to Develop New Diagnostic Tests","summary":"Sysmex and Roche announced a partnership to develop new diagnostic tests for various diseases.","drugName":"","sentiment":"neutral"}],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Abbott Laboratories","Siemens Healthineers","Beckman Coulter"],"therapeuticFocus":["In Vitro Diagnostics (IVD)","Hematology"],"financials":{"source":"yahoo_finance","revenue":3215575787.1031003,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":3215575787.1031003},{"period":"2024-03-31","value":2917607008.267},{"period":"2023-03-31","value":2595140976.5934},{"period":"2022-03-31","value":2299770487.026}],"grossProfit":1719403699.3509002,"grossProfitHistory":[{"period":"2025-03-31","value":1719403699.3509002},{"period":"2024-03-31","value":1533034921.6349},{"period":"2023-03-31","value":1366042680.6794002},{"period":"2022-03-31","value":1204853917.9445}],"rdSpend":198854474.3235,"rdSpendHistory":[{"period":"2025-03-31","value":198854474.3235},{"period":"2024-03-31","value":198519415.1234},{"period":"2023-03-31","value":196357335.002},{"period":"2022-03-31","value":169325011.6128}],"sgaSpend":953641702.2016001,"operatingIncome":574000662.8732,"operatingIncomeHistory":[{"period":"2025-03-31","value":574000662.8732},{"period":"2024-03-31","value":509511249.66150004},{"period":"2023-03-31","value":480772020.91330004},{"period":"2022-03-31","value":426207946.2706}],"netIncome":339288532.2673,"netIncomeHistory":[{"period":"2025-03-31","value":339288532.2673},{"period":"2024-03-31","value":313811389.31630003},{"period":"2023-03-31","value":289440573.9128},{"period":"2022-03-31","value":278743966.9964}],"eps":79.24,"epsHistory":[{"period":"2024-03-31","value":79.24},{"period":"2023-03-31","value":72.91},{"period":"2022-03-31","value":70.163333}],"cash":566250048.169,"cashHistory":[{"period":"2025-03-31","value":566250048.169},{"period":"2024-03-31","value":477345566.4519},{"period":"2023-03-31","value":439117208.282},{"period":"2022-03-31","value":466250681.61840004}],"totalAssets":4205738942.1156,"totalLiabilities":1269014593.8278,"totalDebt":409246364.49950004,"equity":2931932369.5392003,"operatingCashflow":557879890.0382,"operatingCashflowHistory":[{"period":"2025-03-31","value":557879890.0382},{"period":"2024-03-31","value":403999210.9885},{"period":"2023-03-31","value":435166038.4695},{"period":"2022-03-31","value":371340421.7863}],"capex":-315834388.26030004,"capexHistory":[{"period":"2025-03-31","value":-315834388.26030004},{"period":"2024-03-31","value":-317301062.4947},{"period":"2023-03-31","value":-268711156.6085},{"period":"2022-03-31","value":-202514838.0378}],"freeCashflow":242045501.7779,"dividendsPaid":-114305762.20770001,"buybacks":-12643.743400000001,"employees":10533,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":null,"ebitda":null,"period":"2025-06-30","revenue":null,"epsBasic":7.3,"netIncome":null,"rdExpense":null,"epsDiluted":7.3,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1343,"previousClose":1342,"fiftyTwoWeekHigh":2563.5,"fiftyTwoWeekLow":1268,"fiftyTwoWeekRange":"1268.0 - 2563.5","fiftyDayAverage":1395.84,"twoHundredDayAverage":1639.83,"beta":0.65,"enterpriseValue":5264745982.389578,"forwardPE":12.7,"priceToBook":1.67,"priceToSales":1.66,"enterpriseToRevenue":1.66,"enterpriseToEbitda":7.1,"pegRatio":0,"ebitda":741315320.0945996,"ebitdaMargin":23.3,"freeCashflow":0,"operatingCashflow":501754335.7431882,"totalDebt":449017258.5550004,"debtToEquity":14.2,"currentRatio":3.33,"returnOnAssets":6.6,"returnOnEquity":9.2,"analystRating":"2.3 - Buy","recommendationKey":"buy","numberOfAnalysts":15,"targetMeanPrice":1747.33,"targetHighPrice":3300,"targetLowPrice":1300,"dividendRate":36,"payoutRatio":0.47,"fiveYearAvgDividendYield":1.13,"exDividendDate":1774828800,"insiderHeldPercent":26.6,"institutionHeldPercent":31.6,"sharesOutstanding":621911385,"floatShares":518074487,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":74.88,"epsForward":105.88,"revenuePerShare":806.72,"bookValue":803.69,"officers":[{"age":76,"name":"Mr. Hisashi  Ietsugu","title":"Chairman of the Board & Group CEO"},{"age":64,"name":"Mr. Iwane  Matsui","title":"President & Representative Director"},{"age":80,"name":"Mr. Kaoru  Asano","title":"Representative Director"},{"age":68,"name":"Mr. Kenji  Tachibana","title":"Senior Executive Officer, Senior MD & Director"},{"age":null,"name":"Mr. Kensuke  Iizuka","title":"Managing Executive Officer & CFO"},{"age":61,"name":"Mr. Tomokazu  Yoshida","title":"Managing Executive Officer, CTO & Director"},{"age":null,"name":"Takashi  Hatakeda","title":"Executive Officer & Executive VP of Corporate Communication Div."},{"age":null,"name":"Mr. Frank  Buescher","title":"Senior Executive Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.sysmex.co.jp","phone":"81 78 265 0500"}}